NCT02659943 2023-04-19T Cells Expressing a Fully-human AntiCD19 Chimeric Antigen Receptor for Treating B-cell MalignanciesNational Institutes of Health Clinical Center (CC)Phase 1 Completed27 enrolled 25 charts